202 related articles for article (PubMed ID: 17938368)
1. Hemiparkinsonism-hemiatrophy syndrome.
Wijemanne S; Jankovic J
Neurology; 2007 Oct; 69(16):1585-94. PubMed ID: 17938368
[TBL] [Abstract][Full Text] [Related]
2. [Late onset hemiparkinsonism-hemiatrophy syndrome: a case report].
Fukae J; Mochizuki H; Ohashi R; Mitani K; Kawada J; Mizuno Y
Rinsho Shinkeigaku; 2005 May; 45(5):390-3. PubMed ID: 15960180
[TBL] [Abstract][Full Text] [Related]
3. Hemiparkinsonism and hemiatrophy syndrome: a rare observation.
Tessitore A; Russo A; Cirillo M; Giordano A; Marcuccio L; Tedeschi G
Clin Neurol Neurosurg; 2010 Jul; 112(6):524-6. PubMed ID: 20399008
[TBL] [Abstract][Full Text] [Related]
4. Hemiparkinsonism-somatic hemiatrophy syndrome.
Jenkins M; Mendonca D; Parrent A; Jog MS
Can J Neurol Sci; 2002 May; 29(2):184-7. PubMed ID: 12035843
[TBL] [Abstract][Full Text] [Related]
5. Hemiparkinsonism as a late complication of hemiatrophy: a new syndrome.
Klawans HL
Neurology; 1981 May; 31(5):625-8. PubMed ID: 7194980
[TBL] [Abstract][Full Text] [Related]
6. Hemiparkinsonism-hemiatrophy syndrome - report on two cases and review of the literature.
Dziadkiewicz A; Białecka M; Janik P; Sławek J
Neurol Neurochir Pol; 2013; 47(4):387-92. PubMed ID: 23986429
[TBL] [Abstract][Full Text] [Related]
7. Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.
Giladi N; Burke RE; Kostic V; Przedborski S; Gordon M; Hunt A; Fahn S
Neurology; 1990 Nov; 40(11):1731-4. PubMed ID: 2234429
[TBL] [Abstract][Full Text] [Related]
8. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
Miwa H; Mizuno Y
No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694
[TBL] [Abstract][Full Text] [Related]
9. Cerebral hemiatrophy: classification on the basis of MR imaging findings of mesial temporal sclerosis and childhood febrile seizures.
Dix JE; Cail WS
Radiology; 1997 Apr; 203(1):269-74. PubMed ID: 9122406
[TBL] [Abstract][Full Text] [Related]
10. [A case of hemiparkinsonism--hemiatrophy syndrome with early onset].
Iudina VV; Voskresenskaia ON; Iudina GK
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):65-8. PubMed ID: 21465822
[No Abstract] [Full Text] [Related]
11. [A case of Dyke-Davidoff-Masson syndrome with total hemiatrophy].
Hozumi A; Yamazaki K; Hirata K; Iwai T; Katayama S
Rinsho Shinkeigaku; 1996 Oct; 36(10):1143-9. PubMed ID: 8997138
[TBL] [Abstract][Full Text] [Related]
12. Hemidystonia-hemiatrophy syndrome.
Wijemanne S; Jankovic J
Mov Disord; 2009 Mar; 24(4):583-9. PubMed ID: 19097182
[TBL] [Abstract][Full Text] [Related]
13. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.
Burkhard PR; Delavelle J; Du Pasquier R; Spahr L
Arch Neurol; 2003 Apr; 60(4):521-8. PubMed ID: 12707065
[TBL] [Abstract][Full Text] [Related]
14. Progressive facial hemiatrophy revisited: a role for sympathetic dysfunction.
Guo ZN; Zhang HL; Zhou HW; Lan WJ; Wu J; Yang Y
Arch Neurol; 2011 Sep; 68(9):1195-7. PubMed ID: 21911700
[TBL] [Abstract][Full Text] [Related]
15. Hemiparkinsonism with hemiatrophy.
Buchman AS; Goetz CG; Klawans HL
Neurology; 1988 Apr; 38(4):527-30. PubMed ID: 3352904
[TBL] [Abstract][Full Text] [Related]
16. Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome.
Silvers DS; Menkes DL
J Neurol Sci; 2009 Dec; 287(1-2):260-3. PubMed ID: 19766249
[TBL] [Abstract][Full Text] [Related]
17. [Parry-Romberg progressive facial hemiatrophy: pathogenic and evolutionary considerations with regards to a case followed up for a long period of time].
Olivares-Romero J; Casado-Torres A; Serrano-Castro PJ; Guardado-Santervás P; Peralta-Labrador JI; Goberna-Ortiz E
Rev Neurol; 1999 Dec 1-15; 29(11):1032-5. PubMed ID: 10637865
[TBL] [Abstract][Full Text] [Related]
18. Left hemisphere and male sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson Syndrome).
Unal O; Tombul T; Cirak B; Anlar O; Incesu L; Kayan M
Clin Imaging; 2004; 28(3):163-5. PubMed ID: 15158218
[TBL] [Abstract][Full Text] [Related]
19. Camptocormia: pathogenesis, classification, and response to therapy.
Azher SN; Jankovic J
Neurology; 2005 Aug; 65(3):355-9. PubMed ID: 16087897
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.
Chinnery PF; Crompton DE; Birchall D; Jackson MJ; Coulthard A; Lombès A; Quinn N; Wills A; Fletcher N; Mottershead JP; Cooper P; Kellett M; Bates D; Burn J
Brain; 2007 Jan; 130(Pt 1):110-9. PubMed ID: 17142829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
